Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03227991 · ClinicalTrials.gov registry record · NA
Safety Planning Intervention to Reduce Short Term Risk
A NA study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- NA
- Development phase
- 422
- Enrollment target
NCT03227991 is a NA study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 422 participants.
The verdict
NCT03227991, a NA study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 422 participants
- Enrollment target
Study Summary
This study will determine the efficacy of Safety Planning Intervention (SPI) compared to receiving risk factors and warning sign information (RWI) in recent suicide attempters during the 6 months following an acute care visit on: (1) suicidal behaviors; (2) mental health/substance use treatment engagement; (3) suicide-related coping strategies; (4) suicidal ideation; and (5) use of means restriction.
Interventions
- BEHAVIORAL Safety Planning Intervention
- BEHAVIORAL Risk factors and Warning signs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 422 participants |
| Start Date | 2017-09-10 |
| Est. Completion | 2020-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03227991
The ClinicalTrials.gov registry entry for NCT03227991 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 422 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Safety Planning Intervention is the first listed.
NCT03227991 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03227991 about?
NCT03227991 is a clinical study titled "Safety Planning Intervention to Reduce Short Term Risk". This study will determine the efficacy of Safety Planning Intervention (SPI) compared to receiving risk factors and warning sign information (RWI) in recent suicide attempters during the 6 months following an acute care visit on: (1) suicidal behaviors; (2) mental health/substance use treatment enga...
What is the current status of trial NCT03227991?
This trial is currently completed. It is a NA study. The enrollment target is 422 participants. The study started on 2017-09-10. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT03227991?
The interventions under investigation include: Safety Planning Intervention (BEHAVIORAL), Risk factors and Warning signs (BEHAVIORAL).
Who is sponsoring clinical trial NCT03227991?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.